Onconetix, Inc. Increase (Decrease) in Inventories
Onconetix, Inc. (ONCO) reported Increase (Decrease) in Inventories of $64.59 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-13
- Onconetix, Inc. increase (decrease) in inventories for the quarter ending 2026-06-30 was $76.25K.
- Onconetix, Inc. increase (decrease) in inventories for the quarter ending 2026-03-31 was -$11.65K, a 112.80% decline year-over-year.
- Onconetix, Inc. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$462.00.
- Onconetix, Inc. increase (decrease) in inventories for the quarter ending 2025-09-30 was $1.42K.
- Onconetix, Inc. increase (decrease) in inventories for fiscal 2025 was $73.72K, a 18.38% increase from fiscal 2024.
- Onconetix, Inc. increase (decrease) in inventories for fiscal 2024 was $62.27K, a 80.28% decline from fiscal 2023.
- Onconetix, Inc. increase (decrease) in inventories for fiscal 2023 was $315.83K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | $76.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $64.59K 10-Q · filed 2026-08-13 | $64.13K derived: sum of 3 quarters · filed 2026-08-13 | $65.55K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$11.65K 10-Q · filed 2026-05-13 | -$12.12K derived: sum of 2 quarters · filed 2026-05-13 | -$10.70K derived: sum of 3 quarters · filed 2026-05-13 | -$28.95K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | -$462.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $955.00 derived: sum of 2 quarters · filed 2026-03-13 | -$17.30K derived: sum of 3 quarters · filed 2026-08-13 | $73.72K 10-K · filed 2026-03-13 |
| 2025-09-30 | $1.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$16.84K derived: sum of 2 quarters · filed 2026-08-13 | $74.18K 10-Q · filed 2025-11-13 | $23.35K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | -$18.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $72.77K 10-Q · filed 2026-08-13 | $21.94K derived: sum of 3 quarters · filed 2026-08-13 | -$24.06K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $91.02K 10-Q · filed 2026-05-13 | $40.19K derived: sum of 2 quarters · filed 2026-05-13 | -$5.80K derived: sum of 3 quarters · filed 2026-05-13 | $116.32K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$50.83K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$96.82K derived: sum of 2 quarters · filed 2026-03-13 | $25.30K derived: sum of 3 quarters · filed 2026-03-13 | $62.27K 10-K · filed 2026-03-13 |
| 2024-09-30 | -$45.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $76.13K derived: sum of 2 quarters · filed 2025-11-13 | $113.10K 10-Q · filed 2025-11-13 | $129.66K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $122.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $159.09K 10-Q · filed 2025-08-14 | $175.65K derived: sum of 3 quarters · filed 2025-08-14 | $423.02K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $36.97K 10-Q · filed 2025-06-12 | $53.53K derived: sum of 2 quarters · filed 2025-06-12 | $300.90K derived: sum of 3 quarters · filed 2025-06-12 | |
| 2023-12-31 | $16.56K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-02 | $263.93K derived: sum of 2 quarters · filed 2025-06-02 | $315.83K 10-K · filed 2025-06-02 | |
| 2023-09-30 | $247.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-10 | $299.27K 10-Q · filed 2024-12-10 | ||
| 2023-06-30 | $51.90K 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |